Empagliflozin + Linagliptin
Uses of Empagliflozin + Linagliptin
This combination medication is used for the management of type 2 diabetes mellitus.
How Empagliflozin + Linagliptin Works
Empagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidney, reducing reabsorption of glucose and increasing its excretion in the urine. Linagliptin works by inhibiting dipeptidyl peptidase-4 (DPP-4), thereby increasing levels of incretin hormones, which stimulate insulin release and decrease glucagon levels.
Side Effects of Empagliflozin + Linagliptin
Common side effects may include urinary tract infections, genital yeast infections, hypoglycemia, and upper respiratory tract infections.
Warnings
Kidney Limited Data
Limited data are available regarding the impact of this medication on kidney function. Consultation with a healthcare professional is recommended for individuals with kidney issues.
Alcohol Limited Data
Limited data are available regarding the interaction of this medication with alcohol. Caution is advised, and it is recommended to consult with a healthcare professional before combining the two.
Pregnancy Limited Data
There is limited data on the safety of this medication during pregnancy. Consultation with a healthcare provider is recommended to assess potential risks and benefits.
Driving Generally Safe
This medication is generally safe to use while driving. However, individuals should be cautious as hypoglycemia can affect alertness and reaction time.
Liver Limited Data
Limited data are available on the effects of this medication on liver function. Caution is advised, especially for individuals with liver conditions. Consultation with a healthcare professional is recommended.
Lactation Limited Data
Limited data are available regarding the safety of this medication during lactation. Consultation with a healthcare professional is advised to determine potential risks and benefits.